Beximco Sees Turbulence From COVID-19
Remdesivir Success Is Accompanied By Supply Chain Disruption
Executive Summary
A mixed picture has emerged for Beximco in its financial third quarter as a result of the coronavirus pandemic, with its success launching the first generic of remdesivir balanced by disruption to the supply chain.